Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 43 Metastatic Castration-resistant Prostate Cancer 5 Prostatic Diseases 3 Kidney Neoplasms 3 Urogenital Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasms by Site 2 Neoplasms 2 Genital Neoplasms, Male 2 Carcinoma, Renal Cell 2 Thrombocytopenia 1 Renal Insufficiency 1 Prostate Cancer Metastatic 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasm Metastasis 1 Metastatic Hormone Naive Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castration Resistant Prostate Cancer 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Liver Neoplasms 1 High-Risk Localized Prostate Cancer 1 Glioma 1 Glioblastoma 1 Genital Diseases, Male 1 Disease 1 Cytopenia 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Temozolomide 405 Radiotherapy 202 Bevacizumab 157 Radiation 80 Magnetic Resonance Spectroscopy 77 Lomustine 49 Surgical Procedures, Operative 45 Carmustine 41 pembrolizumab 40 Irinotecan 38 Nivolumab 32 Specimen Handling 28 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Drug Therapy 23 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Cyclophosphamide 20 Aminolevulinic Acid 20 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 Blood Specimen Collection 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Vorinostat 13 Sorafenib 13 Ipilimumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Pluvicto × Clear all

NCT07223034 2026-06-04

A Study of 177Lu-PSMA-617 in People With Gliomas

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡